Sterlington Advises Avanos Medical Management Team on $1.27 Billion Acquisition
NEW YORK--(BUSINESS WIRE)--Sterlington advises Avanos Medical management team on $1.27 billion acquisition.
Business Wire7/29/2026Neutral
AVNS
Avanos Medical IncNYSEHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$1.17B
P/E Ratio
—
EPS
$-1.60
Beta
1.57
52W High
$25.49
52W Low
$9.30
50-Day MA
$24.90
200-Day MA
$16.92
Dividend Yield
—
Profit Margin
-10.40%
Forward P/E
30.67
PEG Ratio
—
About Avanos Medical Inc
Avanos Medical, Inc. is a medical technology company focused on providing medical device solutions to improve the quality of life for patients in North America, Europe, the Middle East, Africa, Asia Pacific, and Latin America. The company is headquartered in Alpharetta, Georgia.
Fundamentals
| Revenue (TTM) | $715.90M |
| Gross Profit (TTM) | $358.30M |
| EBITDA | $55.90M |
| Operating Margin | 5.38% |
| Return on Equity | -9.18% |
| Return on Assets | 0.95% |
| Revenue/Share (TTM) | $15.43 |
| Book Value | $16.76 |
| Price-to-Book | 1.50 |
| Price-to-Sales (TTM) | 1.64 |
| EV/Revenue | 1.737 |
| EV/EBITDA | 17.17 |
| Quarterly Earnings Growth (YoY) | -21.70% |
| Quarterly Revenue Growth (YoY) | 8.80% |
| Shares Outstanding | $46.85M |
| Float | $46.03M |
| % Insiders | 3.28% |
| % Institutions | 93.15% |
Historical Volatility
HV 10-Day
0.96%
HV 20-Day
5.85%
HV 30-Day
5.04%
HV 60-Day
4.58%
HV Rank
—
Volatility is currently contracting
Latest News
Avanos Medical, Inc. Stockholders Approve Acquisition by American Industrial Partners
ALPHARETTA, Ga., July 22, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) ("Avanos" or the "Company"), a leading medical technology company, today announced that its stockholders have voted to approve the pending acquisition of Avanos by affiliates of investment funds advised by American Industrial Partners ("AIP") at a special meeting of stockholders (the "Special Meeting") held earlier today.
PRNewsWire7/22/2026Neutral
Avanos Medical, Inc. and American Industrial Partners Receive Required Regulatory Approvals for Pending Merger
ALPHARETTA, Ga. and NEW YORK, July 2, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) ("Avanos") and American Industrial Partners ("AIP") jointly announced the receipt of all required regulatory approvals to complete the pending acquisition of Avanos by affiliates of investment funds advised by AIP (the "Merger").
PRNewsWire7/2/2026Neutral
Avanos Medical Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avanos Medical, Inc. - AVNS
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Avanos Medical, Inc. (NYSE: AVNS) to affiliates of American Industrial Partners. Under the terms of the proposed transaction, shareholders of Avanos will receive $25.00 in cash for each share of Avanos that they own. KSF is seeking to determine whether this consideration and the process that led to i.
Business Wire6/24/2026Neutral
Reasons to Retain Avanos Medical Stock in Your Portfolio for Now
AVNS' SNS momentum, Nexus Medical integration and AIP deal support growth, but tariff costs, margin pressure and PM&R weakness remain headwinds.
Zacks Investment Research6/24/2026Negative
Avanos Medical (AVNS) Up 1.1% Since Last Earnings Report: Can It Continue?
Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock?
Zacks Investment Research6/4/2026Positive
New Strong Sell Stocks for May 15th
AVNS, BKR and CAG have been added to the Zacks Rank #5 (Strong Sell) List on May 15th, 2026.
Zacks Investment Research5/15/2026Negative
Deciphering Avanos Medical (AVNS) International Revenue Trends
Explore Avanos Medical's (AVNS) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
Zacks Investment Research5/11/2026Neutral
AVNS Gains After Posting Q1 Earnings Miss & Revenue Beat, Margins Down
Avanos Medical tops Q1 revenue estimates on strong SNS growth, but margin pressure and PM&R weakness weigh on earnings and profitability.
Zacks Investment Research5/7/2026Neutral
Avanos Medical (AVNS) Lags Q1 Earnings Estimates
Avanos Medical (AVNS) came out with quarterly earnings of $0.22 per share, missing the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.26 per share a year ago.
Zacks Investment Research5/5/2026Negative
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on AVNS and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 7/29/2026